COMP <GO>
CLSK vs BRK-B // 10Y YIELD & FRED MACRO BETA
CleanSpark Inc. (NASDAQ) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: CLSK 8
— BRK-B 5
▲ 10Y YIELD & FRED MACRO BETA LEADER: CLSK
LAST: $7.67 (-6.46%) • MKT CAP: $2.11B
macro-sensitivity
0.93
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
macro-sensitivity
0.61
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLSK VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLSK | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.50% | 11.47% | +3.03 | CLSK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.1x | 9.7x | -2.58 | CLSK | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 2.09% | -20.09 | BRK-B | /fcf-yield <GO> |
| Operating Margin | 41.60% | 27.80% | +13.80 | CLSK | /operating-margins <GO> |
| Net Profit Margin | 47.60% | 22.30% | +25.30 | CLSK | /net-margins <GO> |
| Revenue Growth (YoY) | 102.20% | 3.93% | +98.27 | CLSK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.46 | 2.85 | -1.39 | BRK-B | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | CLSK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 3.55% | +3.15 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.1 | 66.8 | -37.70 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.93 | 0.61 | +0.32 | CLSK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.9x | 24.3x | -19.44 | CLSK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.11B | $1.16T | -$1.16T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLSK REV | BRK-B REV | CLSK GROSS % | BRK-B GROSS % | CLSK FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $766.3M | $371.44B | 55.2% | — | -$495.5M | $25.04B |
| FY 2024 | $379.0M | $371.43B | 56.3% | — | -$250.7M | $11.62B |
| FY 2023 | $168.4M | $364.48B | 44.0% | — | -$24.8M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLSK // BETA 0.93
BRK-B // BETA 0.61